mebendazole has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, MS | 1 |
| Farag, AB | 1 |
| Boys, IN | 1 |
| Wang, P | 1 |
| Menendez-Montes, I | 1 |
| Nguyen, NUN | 1 |
| Eitson, JL | 1 |
| Ohlson, MB | 1 |
| Fan, W | 1 |
| McDougal, MB | 1 |
| Mar, K | 1 |
| Thet, S | 1 |
| Ortiz, F | 1 |
| Kim, SY | 1 |
| Solmonson, A | 1 |
| Williams, NS | 1 |
| Lemoff, A | 1 |
| DeBerardinis, RJ | 1 |
| Schoggins, JW | 1 |
| Sadek, HA | 1 |
1 other study available for mebendazole and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms.
Topics: Antiviral Agents; Atovaquone; COVID-19; Dihydroorotate Dehydrogenase; Dronedarone; Drug Repositionin | 2023 |